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Abstract 
A three-dimensional (3-D) tissue-like assembly (TLA) of human bronchial-
tracheal mesenchymal (HBTC) cells with an overlay of human bronchial epithelial 
(BEAS-2B) cells was constructed using a NASA Bioreactor to survey the infectivity of 
SARS-CoV. This TLA was inoculated with a low passage number Urbani strain of 
SARS-CoV. At selected intervals over a 10-day period, media and cell aliquots of the  
3-D TLA were harvested for viral titer assay and for light and electron microscopy 
examination. All viral titer assays were negative in both BEAS-2B two-dimensional 
monolayer and TLA. Light microscopy immunohistochemistry demonstrated antigen–
antibody reactivity with anti-SARS-CoV polyclonal antibody to spike and nuclear 
proteins on cell membranes and cytoplasm. Coronavirus Group 2 cross-reactivity was 
demonstrated by positive reaction to anti-FIPV 1 and anti-FIPV 1 and 2 antibodies. TLA 
examination by transmission electron microscopy indicated increasing cytoplasmic 
vacuolation with numerous electron-dense bodies measuring 45 to 270 nm from days 4 
through 10. There was no evidence of membrane blebbing, membrane duplication, or 
fragmentation of organelles in the TLAs. However, progressive disruption of 
endoplasmic reticulum was observed throughout the cells. Antibody response to SARS-
CoV specific spike and nucleocapsid glycoproteins, cross-reactivity with FIPV 
antibodies, and the cytoplasmic pathology suggests this HBTE TLA model is permissive 
to SARS-CoV infection. 
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Introduction 
In late 2002, an acute respiratory infectious outbreak was reported from the 
Guangdong province of China (39 or 40 WHO; 32 Peiris et al., 2003). By early 
February 2003, this atypical pneumonia, now termed severe acute respiratory syndrome 
(SARS), had spread to adjacent Hong Kong. It subsequently spread worldwide to North 
America, Europe, and other Asian countries. More than 8,000 patients from over 30 
countries have been exposed to SARS in the past 2 years (39 or 40 WHO). 
That the causal agent to SARS was initially thought to be Mycoplasma 
pneumonia, a Chlamydia sp., or human metapneumovirus, illustrates the difficulties in 
the early definitive diagnosis and adequate laboratory diagnostic procedures (19 Kuiken 
et al., 2003). These early diagnostic efforts were limited to electron microscopy and 
reverse transcriptase PCR (RT-PCR) results from clinical patients. Even after the 
causative agent, a novel coronavirus, was identified from the results of viral genomics 
from laboratories worldwide, SARS was suspected of resulting from the virus in 
combination with other respiratory agents. The identification of virus–like particles in 
transmission electron microscopy cell samples from lung biopsy, pneumocytes from 
postmortem lung samples, and bronchoalveolar lavage samples, combined with the 
genomic data confirmed a previously unknown coronavirus as the potential causal agent 
responsible for SARS (32 Peiris et al., 2003; 4 Drosten et al., 2003; 19 Ksiazek et al., 
2003; 24 Marra et al., 2003; 28 Nichols et al., 2003; and 33 Rota et al., 2003). Despite 
the successes of the initial studies with SARS-CoV, diagnostic and characterization 
efforts were limited by the non-responsiveness of the sera from convalescent patients to 
antibody recognition and by the early dependence on RT-PCR and transmission electron 
microscopy as the only reliable tools for viral identification. 
The unavailability of suitable laboratory cell lines and animal models limited the 
early in-depth investigations of SARS-CoV. Several cell lines routinely used with 
respiratory viruses, such as Madin-Darby canine kidney cell (MDCK), HeLa, and LLC 
MK2, were determined to be unsuitable for SARS-CoV (18 Ksiazek et al., 2003). Vero 
E6 and NCI-H292 showed cytopathic effects after inoculation with oropharyngeal 
specimens collected directly from a SARS-CoV patient. A rhinovirus subsequently 
isolated from the NCI-H292 cell line was later determined not to have a clinical 
association with the SARS-CoV isolate (18 Ksiazek et al., 2003). The coronavirus-like 
SARS-CoV, isolated in Vero E6 cells, was identified by immunohistochemistry using 
cross-reactive anti-coronavirus antibodies, feline infectious peritonitis virus (FIPV), 
transmissible gastroenteritis virus (TGEV), and coronavirus 229E (18 Ksiazek et al., 
2003). The respiratory lesions, epithelial necrosis, formation of hyaline membrane, Type 
2 hyperplasia, and sancta that were experimentally reproduced within cynomolgus 
macaques (Macaca fasicularis) are analogous with clinical manifestations associated 
with SARS-CoV in human patients (19 Kuiken et al., 2003). Virus isolation, 
immunohistochemistry, transmission electron microscopy, and RT-PCR localized the 
SARS-CoV to alveolar epithelial cells and syncytia. When the macaques were infected 
with a Vero E6-cell isolate previously isolated from a SARS-CoV patient, the criteria 
modified by Rivers for viral diseases was met to satisfy Koch’s postulates identifying 
this virus as the cause of disease (6 Fouchier et al., 2003). 
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The characterization by electron microscopy of SARS-CoV morphology from 
either cell culture or human biopsy material is remarkably similar. The virus can attach, 
enter, and uncoat the nucleocapsids within the first 30 minutes of exposure (27 Ng et al., 
2003). Postinfusion entry into the cytoplasm results in the formation of large 
cytoplasmic vacuoles containing electron-dense particles. Electron-dense particles 
within cytoplasmic vacuoles are not limited to SARS-CoV or the Vero E6 cell line. 
Vacuoles with dense particles surrounded by a granular matrix have been associated 
with the human respiratory coronavirus 229E at late as 72 hours p.i. in human fetal 
diploid lung cells (HFDL) (31 Oshiro et al., 1971) and 62 hours p.i. in the human 
diploid lung cell line WI-38 (1 Becker et al., 1967). Virus particle entry into the nucleus 
and blebbing of the nuclear membrane has been reported in a single experiment using 
SARS-CoV material collected from nasal or throat swabs of SARS patients and isolated 
in Vero E6 cells (46 Zhang, et al., 2003). 
Recent data suggest SARS-CoV-like virus or similar coronavirus sequences 
have been detected by RT-PCR from a number of feral animals including raccoon-dogs 
(Nyctereutes proconoides), Chinese ferret badgers (Melogale moschata), bats, and 
monkeys. The highest prevalence is seen in the Himalayan palm civet (Paguma larvata) 
(14 Guan et al., 2003). These data correlate with the elevated seropositive antibody titers 
noted in Chinese workers (40%) who had direct contact with live feral animals and in 
abattoir workers (20%), compared to 5% seen in vegetable workers (44 Yu et al., 2003) 
. In addition to these potential, but unlikely, laboratory animal models, recent 
investigations indicate domestic cats (Felis domesticus), ferrets (Mustela furo), and 
laboratory mice (Mus mus) are capable of shedding SARS-CoV virus either in the upper 
respiratory tract or enterically (25 Martina et al., 2003; 5 Enserink, 2003). The use of 
primates such as the cynomolgus macaques (Macaca fasicularis) as a laboratory animal 
model for vaccine development, pathology studies, and genomic analysis has both 
ethical and financial drawbacks. A laboratory model which could bridge the gap 
between cell culture lines and expensive animal models may be able to present the 
required genomic, proteomic, and physiologic data in repeatable controlled 
environments. 
In this study, novel three-dimensional TLAs of normal human bronchial tracheal 
epithelial cells were engineered to investigate their suitability as a laboratory model for 
SARS-CoV infection and pathogenesis. 
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Materials and Methods 
Three-Dimensional Cell Modeling. Tissue engineering NASA Bioreactors, 
also called rotating-wall vessels (RWVs), were used in conjunction with multicellular 
cocultivation to develop a unique in vitro tissue-modeling system (34 Schwarz et al., 
1992). Briefly, the RWV is a horizontally rotated transparent culture vessel with zero 
headspace and center oxygenation. Two three-dimensional TLAs were constructed at 
the Cellular Environmental Toxicology and Neural Physiology (CETNEP) laboratory at 
Johnson Space Center, Houston, Texas, following a revised methodology (10,11,12 
Goodwin et al., 1992; 1993; 1994). Commercially available HBTC cells (Cambrex 
BioWittaker, San Diego, CA) and BEAS-2B, a SV 40 transformed cell line from ATCC 
(Rockville, Md), were taken from frozen stocks and expanded using a modified tissue 
culture methodology (11 Goodwin et al., 1993). An in-house proprietary media GTSF-2 
(HyClone, Logan, Utah, USA) was used exclusively throughout the expansion of the 
cell lines, and throughout the growth and maintenance of the cultures in the Bioreactor. 
After sufficient clonal expansion, the HBTC cells were combined with Cultispher G 
beads (Percell Biolytical AB Astorp, Sweeden, DG-0001-00), 100 – 200 micron 
macroporous gelatin microcarrier in 55.0 ml NASA Bioreactors (Synthecon, Inc., 
Houston, Texas, USA) for 6 days at the appropriate rotational speed. The Cultispher 
beads served as the initial support matrix for the attachment of the HBTC cells. The 
HBTC cell line has a mesenchymal cell component and an endothelial cell component 
that, after attachment to a single bead, will attach to additional free beads to create an 
expanding bead-cell matrix. On the sixth day postinfusion of HBTC and Cultispher 
beads in the Bioreactor, 3 x 105 BEAS-2B cells were added to the Bioreactor. The 
BEAS-2B cells adhered to the existing bead-cell matrix, the co-culture continued to 
develop until the TLAs were between 2-3 mm and the constructs were ready for 
exposure to the SARS-CoV strain.  
Three-Dimensional Model Characterization. The three-dimensional tissue-
like assembly and two-dimensional tissue culture epithelial cell monolayer were probed 
by immunohistochemistry to determine cellular differentiation characteristics between 
the two models. A three-dimensional HBTE TLA designated for histological and 
immunohistological staining was washed 3 times with gentle agitation in 1x PBS (Celox 
Laboratories Inc, St. Paul, Minn., USA) without magnesium and calcium for 5 minutes. 
The TLA was then transferred to a 50 ml polystyrene tube and covered with 10% 
buffered formalin in PBS (Electron Microscopy Service, Ft. Washington, Pa., USA) 
overnight at 4°C and washed 3 times in the PBS solution. The assemblies were 
centrifuged at less than 200x g to concentrate the bead-cell assembly after which 1 ml of 
2% warm noble agar was added for additional stabilization (30 Olson et al., 1986: 20 
Kung et al., 1990). Assemblies were paraffin-block embedded by standard methods, and 
light sections were cut at 3 to 5 mm on a Micron HM315 microtome (Walldorf, 
Germany). Two-dimensional tissue culture BEAS-2B monolayers were grown on sterile 
glass slides in sterile Petri dishes until the monolayer was 95% confluent on the slide. 
Slides were gently rinsed 3 times in PBS and fixed with 95% ETOH. Slides were 
stained with IHC antibodies on an automated immunohistochemical stainer (DAKO, 
Carpinteria, Calif., USA). Both 3-D and 2-D slide material were examined by a Zeiss 
  
4 
Axioskop (Hamburg, Germany) microscope and images captured with a Kodak DC 290 
Zoom (Rochester, N.Y., USA) digital camera. Table 1 lists the antibodies used to detect 
cell-type-specific markers.  
Virus and Infection of 3-D and 2-D Models. The Urbani strain of SARS-CoV 
was provided to the laboratory of C.J. Peters, M.D. at the WHO Collaborating Centers 
for Tropical Diseases and the UTMB Center for Biodefense and Emerging Diseases, 
University of Texas Medical Branch-Galveston (UTMB), Galveston, Texas. Tissue 
culture flasks of Vero E6 cells were grown to 85% confluency and exposed to the 
SARS-CoV strain for establishment of seed and progeny stock. The pre-exposure viral 
titer assay was determined by TCID50 from a Vero E6 cell monolayer. A single RWV 
bioreactor and the HBTE co-culture were transported from Johnson Space Center to a 
biosafety level 3 laboratory at UTMB. The Bioreactor was set-up, and then the co-
culture and 50.0 ml fresh media were added and allowed to equilibrate for 24 hours in a 
37°C, 5.0% CO2 incubator. At the same time, control T-25 tissue culture flasks of near 
confluent BEAS-2B 2-D monocultures were allowed to equilibrate under the same 
conditions. A second bioreactor with a HBTE co-culture remained at the CETNEP 
laboratory at Johnson Space Center as the negative control.  
On day 0, a frozen aliquot of the SARS-CoV virus was rapidly thawed and 
added to 5.0 ml fresh GTSF-2 media to deliver an inoculum of 1.0 multiplicity of 
infection (MOI) at 37°C. Media were aspirated from the Bioreactor and from the 2-D 
tissue culture flasks, leaving just enough to ensure the cells would be covered to prevent 
drying. An inoculating volume of media with virions was quickly added to each tissue 
culture flask and to the bioreactor, which were then gently rocked to insure uniform 
dispersal of the inoculating media. The bioreactor and tissue culture flasks were 
returned to the incubator and gently rocked every 10 minutes for 60 minutes. After the 1 
hour incubation, a 1.0 ml media aliquot was recovered for viral titration as was an 
aliquot of the 3-D TLA for light and electron microscopy respectively. The bioreactor 
was filled with fresh 55 ml 10% FBS GTSF-2 media and the 2-D monolayer tissue 
culture flasks were covered with 5 ml. of 2% FBS GTSF-2 maintenance media. This 
supernatant aliquot and TLA recovery was repeated at 24 hours and then at 4, 6, 8, and 
10 days post-inoculation. This coincided with a 10% FBS GTSF-2 media exchange of 
25-30 ml into the bioreactor. Tissue samples were either washed in 1x PBS or 0.1 M 
sodium cacodylate buffer pH 7.4 (Electron Microscopy Science, Fort Washington, Pa., 
USA), depending upon whether the tissue was processed for light or electron 
microscopy. Media aliquots were recovered from the 2-D BEAS-2B tissue culture flasks 
and from the 3-D TLAs at the same time points. Media aliquots were recovered from the 
Vero E6 flasks with the initial appearance of cytopathic effects (CPE) and prior to the 
disruption of the cell monolayer. Supernatant samples were frozen down to -70°C for 
viral titer assays. All media and cell aliquots remained in the biosafety hood within the 
Bl-3 laboratory until infectious material was rendered inert by either electron 
microscopy or light microscopy fixatives. 
SARS-CoV TCID50 Assay. TLA and 2-D culture supernatant samples were 10-
fold serially diluted in MEM (Sigma, St. Louis, Mo., USA) supplemented with 2% FBS 
(Gibco, Rockville Ill., USA) to a dilution of 10-5. One hundred microliters of each 
dilution was added to each of 4 wells of a 24-well plate, confluent with Vero E6 cells. 
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Plates were sealed and placed at 37°C for 1 hour. After absorption, 900 µL MEM/2% 
FBS was added to each well and plates were re-sealed and returned to 37°C. Four and 6 
days post-inoculation plates were examined for CPE. Virus titer is expressed as Vero E6 
TCID50 PFU/ml. 
Histology and Immunohistochemistry. TLAs, designated for histological and 
immunohistological staining, were prepared as previously described in the materials and 
methods. They were washed 3 times with gentle agitation in 1x PBS (Cellox 
Laboratories Inc, St. Paul, Minn., USA) without magnesium and calcium for 5 minutes. 
All unstained sections were stored at -20°C until stained with both haematoxylin and 
eosin (H & E), a SARS-CoV specific polyclonal antibody, or FIPV affinity purified 
cross- reactive antibody. 
Rabbit polyclonal antibodies to putative SARS-CoV strain spike (1:400) and 3 
nucleocapsid glycoproteins (1:200 – 1:1200) from Imgenex, Inc. (San Diego, Calif., 
USA) were used to probe day 4 through day 10 light sections. The spike protein 
antibody corresponded to amino acids 84-99, nucleocapsid antibody number 543 to 
amino acids 388- 409, nucleocapsid antibody number 544 to amino acids 396-425, 
nucleocapsid antibody number 548 to amino acids 399-411, and nucleocapsid antibody 
number 549 to amino acids 354-370 (Genebank accession no. NP_828858). The 
sections were deparaffinized by normal procedure. The antigen was retrieved by protein 
kinase or citrate and blocked with a 5% normal rabbit sera-0.05% Tween 20 solution. 
The primary antibody was incubated on the sections for 9 to 15 minutes, rinsed with 
distilled water, and a goat anti-rabbit-horseradishperoxidase second antibody (Dako 
Envision System, Carpinteria, Calif., USA) was applied using an automated 
immunohistochemical stainer (Dako Envision System, Carpinteria, Calif., USA).  
A feline polyclonal antibody to feline infectious peritonitis virus (1/100, FIPV1, 
VMRD, Pullman, Wash., USA) was used to probe day 4 and 6 light sections. The 
second antibody was goat anti-feline IgA conjugated HRP, (1/100, AA125P, Serotec, 
Raleigh, NC, USA). A second primary affinity purified mouse anti-feline IgG to feline 
infectious peritonitis virus 1 and 2, (1/150 MCA2194, Serotec, Raleigh, N.C., USA), 
followed by either goat anti-feline IgG-HRP (AA126P, Serotec, Raleigh, N.C., USA), or 
F (ab′)2 rabbit anti-mouse IgG-HRP (1/150, STAR 13B, Serotec, Raleigh, N.C., USA) 
was used to probe day 4, 6, and 8 light sections. Slides were examined by a Zeiss 
Axioskop (Hamburg, Germany) microscope and images were captured with a Kodak 
DC 290 Zoom (Rochester, N.Y., USA) digital camera.  
Transmission and Immunoelectron Microscopy. Tissue-like assembly 
samples were washed 3 times with 0.1 M sodium cacodylate buffer pH 7.4, then fixed in 
a solution of 2.5% glutaraldehyde-formaldehyde in 0.1 M sodium cacodylate buffer – 
0.3 M sucrose (Sigma, St. Louis, Mo., USA) – 1% DMSO (Sigma, St. Louis, Mo., 
USA) pH 7.4 (Electron Microscopy Science, Fort Washington, Pa., USA) overnight at 
4°C. The fixed tissue was washed 3 times in buffer, and then post-fixed stained in 0.3 M 
tannic acid in 0.1 M sodium cacodylate pH 7.4 for 3 hours at room temperature. The 
tissue samples were washed 3 times in buffer, and then fixed again in 1.0 M osmium 
tetroxide for 1.5 hours at room temperature. Samples were dehydrated in a series of 
graded ETOH, and then embedded in Spurs resin. Samples were sectioned at silver-gray 
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(100 – 300 µm), mounted on Ni grids, and examined under a JEOL-JEM 1010 
transmission electron microscope (JEOL, USA) at 80 kV.  
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Results  
Three-Dimensional Tissue Characterization. The results of comparative 
staining of two- and three-dimensional samples indicated the level of cellular 
differentiation was superior in the TLA constructs. Results reflected in Table 1 
demonstrated greater than or equal to positive staining in human bronchial epithelial 
TLAs compared to positive staining in the bronchial epithelial cells in the 2-D 
monolayer. The cytokeratin, Factor VIII and Von Wilderbrands (VWF) antibodies 
detect epithelial and mesenchymal/endothelial cells, respectively (35 Shima at al, 1988; 
38 Vogel et al, 1984; and 41 Woodcock et al., 1982). Villin and tubulin are cytoskeletal 
proteins found only in epithelial cells. ICAM-1 expression is an indicator of epithelial 
cell differentiation. Epithelial Membrane Antigen, ZO-1, and human mucin are specific 
for mucins produced by secretory human cells. Extracellular matrix component 
Collagen IV was also assayed to determine expression in the tissue-like structures. 
Viral Assay Titer. Viral replication as manifested by titer assays was negative 
throughout the entire time course in both the 3-D HBTE TLA and the 2-D BEAS-2B 
tissue culture flask. 
Light Microscopy. Three-dimensional tissue-like assemblies unexposed and 
exposed to SARS-CoV were sectioned and served as negative histological controls and 
principals. Microscopic evaluations were made over the 10 day course of the 
experiment. The absence of an immunological component to the TLA is indicated by 
hematoxylin eosin (H & E) staining, which shows an increased loss of cell mass within 
the matrix and on the periphery of the bead (Figs. 1, 2, 3) during the 10-day experiment. 
There are no infiltrating macrophages or polymorphonuclear cells responding to pro-
inflammatory cytokines. The eosin stained porous material (Fig. 1) is the gelatinous 
matrix of the Cultispher beads, which took on a bluish tint (Fig. 2, 3). The epithelial 
cells are dense, cytoplasm unremarkable, and nuclei ovoid in the negative controls (Fig. 
1) unlike that observed on day 4 p.i. through day 10 p.i. By day 4 p.i., the cytoplasm 
was granular with pinpoint multiple cytoplasmic vacuoles (Fig. 2). Atypical bronchial 
epithelial had irregularly distributed and condensed nuclei, prominent nucleoli, and 
increasing granular amphophilic cytoplasm. Zones of clearing could be noted between 
clusters of cells. By day 10 p.i., cells appeared less differentiated by definable cell 
membranes; nuclei were condensed. There was a noticeable decrease in the number of 
cells attached to the periphery of the beads, the greater intact cell mass being restricted 
to the core regions of the bead matrix.  
Immunohistochemistry. The negative controls (Figs. 4, 5, 7) were probed with 
either the spike or the nucleocapsid peptide polyclonals. There was a consistent light 
background with the spike and all of the nucleocapsid polyclonals despite efforts to 
eliminate non-specific staining. The blue of the Mayer’s counterstain, the second 
antibody counterstain, was readily absorbed by the gelatinous Cultispher bead. 
Histology sections from those samples exposed to the SARS-CoV from day 4 through 
day 10 inclusive were probed with the spike (Fig. 6) and nucleocapsid antibodies (Fig. 
8, 9), demonstrating positive anti-SARS-CoV reaction. The reaction is confined to the 
cytoplasm with a discontinuous heavier reaction along some cell plasma membranes. 
The variable intensity of positive staining is unique to each polyclonal. Among the 
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nucleocapsid antibodies, polyclonal number 548 (amino acids. 399-411) required the 
highest titration (1/1000) to eliminate nonspecific background and over staining. 
Cross-reactivity of the TLA light sectioned material to an antibody known to be 
reactive against this SARS-CoV strain was investigated using a feline anti-FIPV 1, a 
Group 2 coronavirus (Figs. 10, 11) (S. Zaki,  personal communication). Light sections 
of day 4 p.i. that were stained at a 1/100 dilution of the primary antibody followed by a 
1/100 dilution of goat anti-feline IgA-HRP demonstrated positive cross-reactivity (Fig. 
11). The reactivity was the greatest in the cytoplasm of the cells in the interior of the 
tissue-like assembly and on the most exterior cell membranes. Unlike the granular-like 
cytoplasmic positive reaction observed with the anti SARS-CoV polyclonal antibody, 
this reaction was diffuse and uniform. There was no apparent recognition of host cell 
nuclear proteins or previously undetected virions attached to the cell membrane of the 
periphery cells.  
The TLAs were further probed with a second antibody reactive to FIPV 1 and 2 
(MCA2194, Serotec, Raleigh, N.C., USA) using a mouse anti-feline IgG F (ab′) 2 
fragment conjugated to HRP as the chromate indicator (Figs. 12, 13). The negative 
control TLAs continued to demonstrate the presence of a light endogenous peroxide 
reaction (Fig. 12) but positive cross-reactivity to SARS-CoV could be clearly 
differentiated between the 2 sections (Fig. 13). Unlike the anti-FIPV 1, this antibody 
recognized SARS-CoV related antigen within the nucleus of day 4 through 8 cells, as 
well as in the cytoplasm (Fig. 13).  
Electron Microscopy. Negative control and 1 hour post inoculation samples 
examined by transmission electron microscopy did not indicate cytopathology or virions 
attached to the epithelial cell membranes (Figs. 14, 15). Endoplasmic reticulum, 
mitochondria, nucleus, and cell membranes all appeared to be within normal parameters. 
Polyribosomes were evenly distributed and prominent throughout the cytoplasm. 
Chromatin, including both heterochromatin and euchromatin, was uniform throughout 
the nucleus. Epithelial cell microvilli observed on the apical aspect of the cell were 
intact and appeared normal. 
By day 4 p.i., exposed cells were significantly different from the controls and the 
1 hour exposed cells. Membranes and organelles remained intact, nuclei were uniform, 
not pleomorphic or displaced to 1 side of the cells. When observed, nucleoli appeared 
normal. Intra-nucleolus electron lucent material was only observed in the day 4 p.i. 
samples (Fig. 16). Microvilli were still present and did not appear to have any gross 
histological changes (Fig. 16). Mitochondria, when observed, were at a lower 
percentage per cell and swollen. Endoplasmic reticulum was disrupted rather than 
linear. The intra-endoplasmic compartment was noticeably distended, with the 
polyribosomes being less distinguishable and more widely diffused throughout the 
cytoplasm (Fig. 17). Translucent cytoplasmic vacuoles proximal to the cell plasma 
membrane did not have an electron-dense inner membrane suggestive of an exogenous 
origin. Likewise, cell plasma membranes did not appear to be disrupted or noticeably 
invaginated which could indicate postendocytosis origin of the vacuoles (Fig. 16). 
Double-membraned vacuoles with electron-dense material were seen throughout the 
cytoplasm (Figs. 16, 17); especially in those regions that previously would have been 
endoplasmic reticulum cysternae. 
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The electron-dense material within the vacuoles was pleomorphic, varying from 
dense aggregates located towards the periphery of the vacuoles to semi-translucent 
material diffused throughout the vacuole. Some electron dense aggregates within a 
larger vacuole appeared to have well defined margins and a core (Figs. 16, 17, 20). 
These defined electron dense structures ranged between 45-270 nm in diameter. 
Clear areas of cell membrane disruption and necrosis were observed through the 
TLAs by day 6 p.i. (Figs. 18, 19). Within these areas, the junction between the cells 
adjacent to the beads increased from the day 4 p.i. aliquots. Polyribosomes remained 
evident (Fig. 18, 19), but observing mitochondria became increasing more difficult. 
Nuclear chromatin material appeared granular with widely diffused areas that were 
electron-lucent. Cytoplasmic vacuoles with the electron-dense circular material were 
smaller than in day 4 p.i. aliquots, 992.5 nm to 1505.3 nm, respectively. However, the 
vacuoles were greater in number and tended to be concentrated in those areas that had 
identifiable endoplasmic reticulum. Cell membrane microvilli were few in number or 
hard to clearly identify.  
Day 8 p.i. aliquots had increased zones of cell debris within the interior of the 
TLAs along with an increasing number of cells detaching from the beads. Cell 
membranes were not observed blebbing, but they appeared to be disrupted by a lytic 
mechanism. The cytoplasm was almost completely devoid of polyribosomes (Fig. 20). 
Neither mitochondria nor endoplasmic reticulum could be observed in those cells that 
had large numbers of cytoplasmic vacuoles. The cytoplasmic vacuoles appeared to be 
orientated to the opposing poles in some cells rather than widely distributed as observed 
in the day 6 p.i. aliquots (Fig. 18). The electron-dense bodies with the vacuoles might 
have coalesced (Fig. 20), but the bodies were greater in number and more clearly 
defined than in previous post-infection aliquots. Translucent areas within the cytoplasm 
and cytoplasmic vacuoles were observed clearly for the first time (Fig. 20). Electron-
translucent areas not clearly defined by a cytoplasmic membrane became increasingly 
evident. 
By day 10 p.i., few intact cell clusters or cells remained attached to beads. The 
cytoplasm took on a granular appearance. This diffuse granularity was also noted in the 
remaining intact nuclei along with perinuclear regions of necrosis (Fig. 20). The 
membrane-defined cytoplasmic vacuoles had fewer electron-dense granular bodies; the 
remaining bodies had a more consolidated appearance (Figs. 20, 21). In some vacuoles, 
the granular bodies were restricted to the periphery of vacuole with the remaining 
vacuole volume taking on very electron-dense pleomorphic shapes. Some were 
horseshoe-shaped; others were shaped like commas or hyphens. Although the 
cytoplasmic vacuoles observed in earlier time points were scattered throughout the 
cytoplasm, these vacuoles either directly abutted the plasma cell membrane or were in 
the perimembrane space (Fig. 21). Some cells had either what could be termed “ghost” 
endoplasmic reticulum or, in select areas of the cytoplasm adjacent to translucent 
vacuoles, faint endoplasmic reticulum (Fig. 21). Large (2.4 micron) electron dense 
structures with an inner tubular array were observed in a number of late experiment 
cells. These structures had a defined architecture; however, a limiting membrane could 
not be observed. 
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Cytoplasmic inclusion material earlier described as a late maturation 
development (1 Becker, et al., 1967; 31 Oshiro et al., 1971) was observed throughout 
the day 4 p.i. through day 10 p.i. aliquots (Figs. 16, 20). 
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Discussion 
A 3-D TLA of human bronchial epithelial cells was successfully engineered to 
investigate its suitability as a laboratory model for SARS-CoV infection and 
pathogenesis. Comparison of the degree of cellular differentiation in the TLA model to 
the differentiation in normal human bronchial tissue (Table 1) indicates its similarity to 
normal human bronchial tissue. As with Collagen IV, Mucin, and ZO-1, the level of 
differentiation expression is comparable between the 3-D TLA and normal tissue. A 
two-fold or greater level of marker expression observed in the 3-D models versus 2-D 
monolayers using analogous antibody dilutions supports the hypothesis of functionality 
differences between the two models. Analogous levels of differentiation between 
normal tissue and the 3-D TLA, observed with Cytokeratin 18, ZO-1, ICAM-1, and 
Factor VIII, supports the hypothesis that cell functionality as measured by the 
differentiation markers more closely resembles normal human tissue in the 3-D model 
than the 2-D model. Although the 3-D model does not have the histo-architecture of 
normal in vivo tissue, its functionality is comparable. The distal edge of the 3-D TLA 
has microvilli (Figs. 14, 15, 16) indicating apical polarity, essential to viral cell-cell 
transport via the microvilli movement along the air-liquid interface. Apical polarity is 
not usually seen in 2-D tissue culture systems. The model’s lack of a lymphoid cell 
component is not a deficit with regard to studying the innate cellular response of the 
target cell. Measurable cellular responses to the virus are the host cell’s unique innate 
response to the microbial pathogen. This property allows for novel investigations 
without the influences of an acquired response or the sequelae of adjacent cells 
responding to pro-inflammatory cytokines. The flexibility of the 3-D TLA to microbial 
infectivity and response investigations is amply demonstrated in data from Norovirus 
(12 Goodwin, T.J, et al., 2000), Salmonella typimurium (29 Nickerson, C.A. et al., 
2002), Respiratory Syncytial Virus in a comparable lung model (13 Goodwin, T.J. et al., 
2003; 23 Lin, Y-H, et al., 2003), West Nile Virus, N.Y. 1999 Strain, Dengue-2, New 
Guinea Strain, and Vesticular Stomatitus Virus, Indiana Strain experiments 
(unpublished data). 
The lack of a recoverable viral titer and the apparent lack of observable 
cytopathic effects in the 2-D tissue flasks initially indicated the unsuitability of this 3-D 
model to SARS-CoV investigations. Earlier investigations with MDCK, HeLa and LLC 
MK2 cell lines, routinely used with respiratory viruses, found them to be unsatisfactory 
for SARS-CoV investigations (18 Ksiazek, T.G., et al., 2003). In fact, they may 
demonstrate some of the same properties observed in the BEAS-2B cell line. The 
cytopathic effects defined by rounding of cells, loss of adherence to the plastic surface 
of the tissue culture flask, observable granulation in the cytoplasm in the 2-D 
monolayers at the end of this investigation may not be characteristic of the SARS-CoV 
in these particular cell lines. Clinical descriptions of pulmonary pathology resulting 
from SARS-CoV infection include unremarkable upper respiratory tract, either 
unilateral or bilateral consolidation, mild pleural effusion with clear serous fluid, and 
pulmonary edema (37 Tse G.M-K., et al., 2004; 7 Franks T.J., et al., 2003; 3 Ding, Y., et 
al., 2003). Intra-alveolar exudates consisting of histocytes and acute inflammatory 
exudates were noted only in those cases that had concurrent secondary bacterial 
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infections. Atypical pneumocytes had a focal distribution and were described as 
multinucleated giant pneumocytes, granular amphopilic cytoplasm, and eosinophilic 
nucleoli. A lack of prominent upper respiratory tract pathology was noted. The 
morphological changes in the bronchial epithelium were denudation, loss of cilia, and 
squamous metaplasia (28, Nicholls, J.M., et al., 2003; 21 Lang, Z.W., 2003). Giant cell 
formation or synctial development was not observed in the BEAS-2B 2-D monolayers, 
which may indicate this cell line does respond differently to the SARS-CoV.  
The lack of budding virions and infective progeny virions may be a 
characteristic of SARS-CoV interaction with BEAS-2B host cell genomics. The 
interactions of the virus with the host cell genome produces genomic RNA, antigenomic 
RNA, and, in some cases, subgenomic-length RNAs, all in the presence of the host cell 
mRNAs, tRNAs and rRNAs, resulting in infectious virions (26 Narayanan, K., 2001). In 
some cases, however, combining nongenomic viral RNAs and cellular RNAs results in 
noninfectious viruses. In this instance, the observation of cytoplasmic vacuoles (Figs. 
16, 17) on day 4 p.i. indicates the S1 subunit of the coronavirus spike protein, 
responsible for host cell receptor recognition is apparently functional along with the S2 
integral membrane portion responsible for viral and cellular membrane fusion (43 Ying, 
W., et al., 2004). The increasing numbers and complexity of these intra-cytoplasmic 
vacuoles and the electron dense particles through day 10 p.i., without the observable 
virion packaging, the presence of characteristic spike envelope proteins, and a definable 
nucleocapsid suggests post-translational modifications. These modifications either of 
viral or host origin allow limited packaging in the post-Golgi complex (Fig. 17) but 
interfere with the expression of the envelope. Thus they inhibit virion exocytosis from 
the cells. With certain coronavirus such as MHV, FIPV and TGEV, the membrane 
protein M directs the intracellular budding (17 Klumperman J., 1994). These 
coronaviruses bud exclusively into smooth-walled, tubulovesicular membranes located 
between the rough endoplasmic reticulum and the Golgi complex. However, some M 
proteins are transported beyond this trans-Golgi region and are held in retention. Within 
the coronavirus, the M protein and the spike protein S are two critical protein 
constituents within the envelope as it is acquired by budding at intracellular membranes. 
Double membrane cytoplasmic vacuoles (Figs. 16, 18, 19) were observed in the 
perinuclear region of the cytoplasm and within the intra-reticular endoplasmic 
compartment. However, viral budding was not observed from these cytoplasmic 
membranes. Cell loss from the beads by day 10 p.i. (Fig. 3) might be due in part to viral 
interference with host cell signal transduction pathways such as apoptosis and 
differentiation via the activator protein (AP-1), as well as from mechanical disruption by 
cytoplasmic vesicle (15 He, R., et al., 2003; 36 Thiel, V., et al., 2003). Why viral 
shedding did not take place in the course of the experiment remains to be elucidated 
with additional experiments into the viral genomic interactions with BEAS-2B host 
genome. Positive antigen-antibody response, in addition to the observations of the 
cytoplasmic vacuoles by transmission electron microscopy (TEM), confirms SARS-
CoV entry despite the lack of traditional cytopathic effects and a recoverable viral titer. 
The positive IHC staining with all antibodies probes clearly shows the presence 
of SARS-CoV antigen in the cytoplasm, nucleus, and cell plasma membrane of the 
BEAS-2B cells. Positive antibody binding was confirmed with the observed results of 
the negative controls and those sections stained only with the DAB-conjugated second 
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antibody (Figs. 4, 5, 10, 12). Sections stained with normal rabbit or normal goat serum 
as the first antibody did not demonstrate antibody staining (data not presented). The 
SARS-CoV polyclonal specific spike and nucleocapsid protein antibodies clearly 
recognized SARS-CoV antigens to a differing degree in the cytoplasm and along the 
plasma cell membrane (Figs. 6 - 9). Anti-SARS-CoV spike antibody staining at day 4 
p.i. was restricted to the cytoplasm with no nuclear involvement. The intensity of 
staining even at a 1/100 dilution was light and diffuse; however, the cytoplasm did have 
a granular appearance throughout the course of the experiment (Fig. 6). Anti-
nucleocapsid protein # 543 (amino acid 388-409) could be differentiated from # 548 
(amino acid 399-411) and # 549 (amino acid. 354-370) by the level of intensity (Fig. 9), 
recognition of antigen along the plasma cell membranes (Figs. 8, 9), and increased 
antigen recognition within the nucleus (Fig. 9). Coronavirus nucleoprotein involvement 
in the host cell nucleolus has been reported with avian bronchitis (16 Hiscox, J.A., 
2001), TGEV (42 Wurm, T., 2001), and MHV (22 Li, H-P., 1997). SARS-CoV cross-
reactivity with monoclonal anti-feline infectious peritonitis virus 1 (FIPV-1) is similar 
to the earlier cross-reactivity observations involving the Urbani strain (18 Ksiazek, T.G., 
et al., 2003: Zaki, S., personal communication 2003) and a second anti-feline FIPV 1 
and 2 antibody, which had never been tested against SARS-CoV, was noted. Both anti-
FIPVs recognized SARS-CoV antigen within the host cell nucleus, however, the second 
FIPV had a higher affinity for the antigen as seen by the heavier staining reaction. The 
intra-nuclear antigen recognition by the FIPV antibodies may be similar to the 
observations with transmissible gastroenteritis virus (TGEV) and MHV localizing in the 
nucleolus while the host cells are undergoing cell division (42 Wurm, T., et al., 2001). 
This involvement plays a determining role in the disruption of the cell cycle in 
interphase, thereby inhibiting cytokinesis in those cells infected with avian coronavirus 
infectious bronchitis virus (IBV) (2 Chen et al., 2002). Nucleoli were observed in a 
percentage of cells in those sections stained with the anti-FIPV antibodies, generally late 
into the experiment (Fig. 13). SARS-CoV antigen was present in the nucleus, but 
whether it had an active role in the disruption of the cell cycle in the TLA remains 
speculative. 
Examination of ultra-thin sections by transmission electron microscopy indicated 
similar and dissimilar observations with other coronavirus investigations. Cytoplasmic 
vacuole development and proximal membrane vacuolation in negative controls and 1 
hour sections (Figs. 14, 15) differ from the observations of SARS-CoV in Vero E6 2-D 
tissue cultures (46 Zhang, et al., 2003; 27 Ng, M.L. et al., 2003). Vacuolation at the cell 
plasma membrane, well defined electron dense cytoplasmic vacuoles with electron 
dense particles budding from the intra-cytoplasmic membrane into the vacuole lumen, 
were characteristics observed in the 3-D TLA. Comparison of the negative controls to 
exposed sections from day 4 p.i. through day 10 p.i. confirms the loss of discernable 
endoplasmic reticulum (Figs. 16, 18, 19, 21), swelling and loss of mitochondria, and 
alterations in the distribution of chromatin (Figs. 16, 18). In few instances, small 
translucent vacuoles were seen just below the plasma cell membrane at 1 hour (Fig. 15). 
Sub-membrane vacuoles observed on day 4 p.i. would be more suggestive of 
cytoplasmic vacuoles with assembled virions preparing to bud from the cell membrane 
than newly acquired virions (Fig. 16).  
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Multiple cytoplasmic vacuoles with electron-dense particles were clearly visible 
from day 4 p.i. through day 10 p.i. The vacuoles were pleomorphic, and those 
perinuclear did not appear to be smaller or more condensed than those distal to the 
nucleus at day 4 p.i. (Fig. 16). At day 4 p.i. some vacuoles appeared to be in the intra-
endoplasmic reticulum compartment (Fig. 17). The vacuole’s double membrane could 
be better observed at higher magnification at day 4 p.i. The electron dense particles were 
generally clustered near one edge but not in direct contact with the vacuole membrane. 
Particles ranged from 45 to 270 nm in diameter, larger than the previously described 
SARS-CoV maturation particles from WI-38, human fetal diploid lung cells, or Vero E6 
cell lines (1 Becker et al., 1967; 31 Oshiro, et al., 1971; 27 Ng, et al., 2003; 46 Zhang, et 
al., 2003).  
Observations with either coronavirus 229E or SARS-CoV regarding cytoplasmic 
vacuoles, electron dense granular particles, and morphological changes within the host 
cell suggest the human bronchial epithelial TLA is a suitable model for investigations 
into coronavirus infectivity and pathogenesis. The TLA remained viable in culture three 
times longer than in 2-D tissue cultures. It is engineered with normal human cells, the 
response to the microbial agent is of human cell origin, and it is repeatable using the 
same cell lines and potentially the same cell passage number. Positive antigen-antibody 
response, in addition to the TEM observations, confirms SARS-CoV entry into the cells 
despite the lack of traditional cytopathic effects and a recoverable viral titer. Although 
the significance of not detecting progeny virions cannot be overlooked, the 
comprehension of the viral-host cell genomic interactions may be the greater 
consideration to potential vaccine development and the characterization of coronavirus 
influenced histopathology. 
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Table 1 
Tissue 
Characterization 
Stains 
Normal Hu 
Lung Tissue 
3-D HBTE 
TLA 
2-D BEAS-2B 
Cells 
ZO-1 3+ 4+ 1+ 
Epithelial 
Membrane Ag. 
(EMA) 
4+ 2+ 0 
ICAM-1 (CD54) 3+ 4+ 0 
Villin 2+ 3+ 1+ 
Tubulin 3+ 4+ 1+ 
Cytokeratin 18 3+ 4+ 1+ 
VWF/Factor VIII 4+ 3+ 1+ 
Collagen IV 4+ 4+ 2+ 
Hu Mucin 4+ 4+ 1+ 
Comparison of normal human bronchial tracheal tissue differentiation to  
3-D TLA  and 2-D tissue culture monolayer indicated by IHC staining. ND = 
Not Done 
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Figures  
 
Figure 1. Unexposed HBTE control. Cells are normal, cytoplasm is 
agranular, nuclei are ovoid, and nucleoli have taken up the eosin stain. 
H&E 400x 
Figure 2. HBTE SARS-CoV, day 4 p.i. cells show little histopathology, 
cytoplasm has granular appearance.  H&E 400x 
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Figure 3. HBTE SARS-CoV. Day 10 p.i. cells remaining are in the core of 
the gel matrix. Cytoplasm has pale eosin blush, nuclei are pleomorphic. 
Proportionally large nuclei, but no multinucleated cells or syncytia.  H&E 
400x 
Figure 4. HBTE Negative Control SARS-CoV specific polyclonal spike 
antibody probed against a day 4 p.i. matched unexposed 3-D TLA. Uniform 
light endogenous peroxide reaction on the peripheral cells. Azure stain from 
the Mayer’s counterstain. 400x 
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Figure 5. HBTE Negative Control. SARS-CoV specific polyclonal anti-nucleocapsid 
protein # 543 probed against a day 4 p.i. matched unexposed 3-D TLA. Azure stain 
from the Mayer’s counterstain. 400x 
Figure 6. HBTE SARS-CoV specific polyclonal anti-spike antibody. 
Day 4 p.i. Uniform light stain in the cytoplasm, especially on the 
peripheral cells. 400x 
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Figure 7. HBTE. Negative Control SARS-CoV coronavirus specific anti-
nucleocapsid polyclonal # 543 probed against a day 4 p.i. matched unexposed 3-D TLA. 
400x 
 
Figure 8. HBTE. SARS-CoV specific polyclonal nucleocapsid protein antibody 
# 548. Greater staining intensity along cell membrane outlining the interface of the 
Cultispher bead and the basal border of the HBTE cell (arrows). Cytoplasm has 
granular appearance, some antigen-antibody reaction in the nuclei. on day 4 p.i. 400x 
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Figure 9.  HBTE SARS-CoV specific polyclonal nucleocapsid protein 
# 549. Greater staining intensity along the cell membrane (small arrows). 
Cytoplasm has less reaction than the cell plasma membrane day; distinct 
granular particles observed in the cytoplasm, nuclei are not uniformly 
stained. Day 4 p.i. 400x   
Figure 10.  HBTE. Negative Control Cross-reactivity of anti-FIPV-1 
antibody to SARS-CoV. A day 4 p.i. matched unexposed 3-D TLA 
probed with anti-FIPV-1 Ab (1/100). No observable reaction. Azure 
stain from the Mayer’s counterstain. 400x 
 
 
  
25 
Figure 11.  HBTE. Cross-reactivity of anti-FIPV-1 antibody to SARS-
CoV. A day 4 p.i. exposed 3-D TLA probed with anti-FIPV 1 Ab (1/100). 
Cross-reactivity in the cytoplasm of peripheral and interior cells. 
Cytoplasm has granular appearance; few nuclei appear to have taken up 
the stain. 400x 
Figure 12.  HBTE. Negative Control. Cross-reactivity of anti-FIPV 1 
and 2 Ab to SARS-CoV. A day 6 p.i. matched unexposed 3-D TLA 
probe with anti-FIPV 1 & 2 (1/100) and counterstained with F (ab′) 2 
(1/150). Light brown stained areas are the result of endogenous 
peroxide reactions. Azure stain from the Mayer’s counterstain. 1000x.  
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Figure 13.  HBTE. SARS-CoV exposed day 6 p.i. TLA at a 1/100 
dilution probed with anti-FIPV 1 & 2. Positive cross–reaction with 
SARS-CoV. Staining evident on the cell plasma membranes of 
peripheral cells and cytoplasm of interior cells. Cytoplasm has granular 
appearance and nuclei are heavily stained. 1000x 
Figure 14.  HBTE. TEM of a negative control TLA section. The nucleus (N), 
endoplasmic reticulum (arrows) and mitochondria (arrow heads) appear 
within normal parameters. The differentiation characteristic, cellular 
polarity, is indicated by the apical microvilli (Ac). Original magnification 
was used, 12000x. 
N 
Ac 
200 nm 
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Figure 15.  HBTE. TEM of exposed TLA at 1 hour p.i. Mitochondria are 
visible, not swollen; endoplasmic reticulum (arrowheads) are clearly 
defined distal to the nucleus; and the nucleus  appears normal. Single 
intracellular translucent vacuole (arrow) are near the cell plasma 
membrane. Neither electron-dense-particles nor vacuolar membrane is 
noticeable. Original magnification was used, 12000x. 
Figure 16.  HBTE TEM of exposed TLA at day 4 p.i. Nucleus (N) and 
nucleolus (Nc) are intact; nuclear chromatin is uniformly dense. Nucleolus has 
pinpoint translucent areas within its border. There were multiple cytoplasmic 
vacuoles (arrowheads) with electron-dense material. Sub-membrane vacuoles 
(arrows) are translucent without clearly defined cytoplasmic membrane. 
Large cytoplasmic vacuole (large open arrow) contains multiple electron-
dense granules, and defined inner compartments with granular structures and 
is bordered by defined translucent zone. Original magnification was used, 
7500x. 
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Figure 17.  HBTE high magnification TEM of exposed TLA at day 4 
p.i. Cytoplasmic vacuole separated from cell cytoplasm by translucent 
membrane (large open arrow) with well-defined electron-dense 
granular particles (arrow). Vacuole is positioned in the intra-
endoplasmic reticulum compartment. Original magnification was used, 
60000x. 
Figure 18.  HBTE TEM of exposed TLA at day 6 p.i. The nucleus (N) is 
pleomorphic, shifted towards the edge of the cell, has granular 
chromatin material with several electron dense particles within the 
nuclear membrane (arrowheads). The cytoplasmic vacuoles with 
electron dense granules are compact, defined by translucent border 
(small arrow). Translucent cytoplasmic vacuoles are pronounced 
(arrows). Neither mitochondria, endoplasmic reticulum, nor 
polyribosomes are noticeable. Original magnification was used, 7500x. 
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Figure 19.  HBTE TEM of exposed TLA at day 8 p.i. Three cells are in close 
proximity to each other (labeled 1,2,3). Cell 1 has intact nucleus (N) with 
numerous perinuclear cytoplasmic vacuoles (arrowhead) containing electron-
dense granules. Cell 2 has numerous cytoplasmic vacuoles containing 
pleomorphic electron dense granules (arrows). Cell 3 has distinctive 
polyribosomes and apical microvilli (Ac). Original magnification was used, 
7500x. 
Figure 20.  HBTE higher magnification TEM of exposed TLA at day 8 p.i. 
shows Cytoplasmic vacuoles with multiple electron-dense, well-defined 
circular granular bodies (arrowhead). Cytoplasmic vacuolar membrane can 
be distinguished with a translucent zone between the membrane and granular 
bodies (arrow). Particles with higher electron density are seen with the same 
cytoplasmic vacuoles, but are pleomorphic and restricted to the periphery of 
the vacuole (double arrowhead). Original magnification was used, 25000x. 
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Figure 21.  HBTE high magnification TEM of exposed TLA at day  
10 p.i. Numerous cytoplasmic vacuoles with small pleomorphic 
electron-dense particles are adjacent to cell plasma membrane 
(CPM). In some vacuoles, the electron-dense particles are centrally 
located and in others they appear to lie adjacent to vacuole membrane 
(open arrows). Translucent vacuoles devoid of electron-dense material 
are centrally located within the cell. Cytoplasmic inclusion bodies are 
also located mid-cell (arrowheads). Original magnification was used, 
75000x. 
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